Dr John Comley was previously Manager of HTS Technologies at PerkinElmer, Turku, and was responsible for the development of SmartStation concept. Dr Comley has over 20 years experience in Drug Discovery and was formerly Principal Scientist at GlaxoWellcome, UK, where he pioneered assay miniaturisation. Dr. Comley undertook post-doctoral work in the Pharmacology Department, University of Vermont and Biochemistry Department, Liverpool University. He has a Ph.D. in Parasite Chemotherapy from Imperial College, London University.